Friday, October 26, 2012

EU Parliament certifies Israeli pharmaceuticals

The European Parliament voted in favor of simplifying the sale of Israeli pharmaceuticals within the European Union.

With Tuesday's vote in Strasbourg, France, the parliament approved “a very important technical-commercial agreement,” Yigal Palmor, a spokesman for the Israeli Ministry of Foreign Affairs, told JTA in an email.

“The agreement recognizes that the standards of the Israeli pharmaceuticals industry is equal to that of European standards,” he said.

The vote -- 379 in favor to 240 against and 40 abstentions -- means that Israeli medicines can be marketed in Europe without delay and without further control, which is how European pharmaceuticals are marketed in Israel. -- JTA

 To read more, click here.

No comments:

Post a Comment